Robust Identification of Gene Fusions from RNA Sequencing Data and Their Potential as Biomarkers of Drug Response
Year: 2021
Type: dissertation
Abstract: Gene fusions occur in solid tumors and hematological malignancies, formed as the result of somatic genomic rearrangements. Gene fusions have been shown to be associated with drug response and can therefore be seen as robust, clinically relevant biomarkers. New fusions can be detected through the use of bioinformatic tools, namely fusion detection algorithms, for which over 30 different tools have been published. However, fusion calling algorithms are error-prone, slow, and call numerous false positives. I show that by using RNA-seq data from biological replicate cell lines, the accuracy of fusion predictions can increase, thereby increasing the reliability of the fusion candidates for use in large-scale gene fusion-drug interaction experiments. I also identify strong drug response in the FO393400.1/NOL4L fusion, showing the potential for novel gene fusions as predictive biomarkers of drug response.
Source: TSpace (University of Toronto)
Author: Keimakh, Denis
Institution: University of Toronto
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7052293820
